Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus.

Eye Contact Lens

Ophthalmology Department (H.K.), Bingol Women's Health and Children's Hospital, Bingol, Turkey; Ophthalmology Department (M.K., E.Y.), Ankara Ulucanlar Eye Training and Research Hospital, Ankara, Turkey; Ophthalmology Department (K.T., M.I.), Ercis State Hospital, Van, Turkey; and Ophthalmology Department (K.O.), TOBB ETU Hospital, Ankara, Turkey.

Published: September 2020

AI Article Synopsis

  • The study aimed to assess how effective topical nepafenac is at increasing pupil diameter in diabetic patients undergoing cataract surgery.
  • Two groups of patients (with and without diabetes) had their pupil size measured before and after applying nepafenac to one eye and cyclopentolate to both.
  • Results showed that diabetic patients experienced a notable increase in pupil size from the application compared to fellow eyes, indicating that nepafenac has an additional benefit for pupil dilation in these patients.

Article Abstract

Objectives: To evaluate the additive effect of topical nepafenac on pupil diameter (PD) in patients with diabetes mellitus (DM) and cataract.

Methods: This prospective comparative study included the patients having cataract surgery with and without DM. Two consecutive PD measurements were taken using an automatic quantitative pupillometry system (MonPack One, Metrovision). A baseline measurement was taken, then one drop of nepafenac % 0.1 (Nevanac; Alcon, Fort Worth, TX) was instilled only to the eye that will be operated on (study eye). Cyclopentolate 1.0% (Sikloplejin; Abdi İbrahim, İstanbul, Turkey) was instilled to both eyes (study eye/fellow eye) 5 minutes later. The second measurement was taken at 1 hour after this application.

Results: The DM group consisted of 43 patients, and the control group consisted of 39 participants. The baseline PDs of both eyes were similar in the DM group (P=0.070) and the control group (P=0.345). The change in pupil size from baseline to mydriasis was statistically significantly greater in the study eyes (2.69±0.53) than fellow eyes (2.54±0.61) in the DM group (P=0.009), but there was no statistically significant difference in the control group (2.94±0.63 vs. 2.86±0.58). When the groups were compared, the PD changes were similar in the study eyes between groups (P=0.065), while the PD changes in the fellow eyes were lower in the DM group (P=0.017).

Conclusions: Nepafenac has been shown additive effect on pupil dilation in diabetic patients before cataract surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICL.0000000000000657DOI Listing

Publication Analysis

Top Keywords

control group
12
additive topical
8
topical nepafenac
8
patients diabetes
8
diabetes mellitus
8
patients cataract
8
cataract surgery
8
group consisted
8
study eyes
8
fellow eyes
8

Similar Publications

Latent tuberculosis prevalence in healthcare workers in Laos: a cross-sectional study.

Trop Med Health

January 2025

LaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Laos.

Background: Individuals with latent tuberculosis infection (LTBI) have a high risk of active infection, morbidity and mortality. Healthcare workers are a group who have increased risk of infection and onward transmission to their patients and other susceptible individuals; however, LTBI is often undiagnosed, and individuals are asymptomatic. Interferon gamma release assays (IGRA) can detect evidence of TB infection in otherwise asymptomatic individuals and are a good indication of LTBI.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to use the advanced technique of Network Intervention Analysis (NIA) to investigate the trajectory of symptom change associated with the effects of self-control training on youth university students' chronic ego depletion aftereffects.

Methods: The nine nodes of chronic ego depletion aftereffects and integrated self-control training were taken as nodes in the network and analyzed using NIA. Networks were computed at the baseline, at the end of treatment, at 1-, 3-, 6-, 9- and 12-month follow up.

View Article and Find Full Text PDF

Background: Astragalus injection has been utilized in traditional Chinese medicine to treat a variety of diseases. The purpose of this systematic review was to evaluate the effectiveness of Astragalus injection in the treatment of viral myocarditis.

Methods: English databases such as PubMed, Cochrane Library, and EMBASE, and Chinese databases of Sino Med, China National Knowledge Infrastructure (CNKI), the VIP Information Resource Integration Service Platform, and Wanfang Data Information Site, were searched from their inception until May 1, 2024.

View Article and Find Full Text PDF

Objective: To investigate the application value of arthroscopic channel modification in meniscal injury repair.

Methods: We retrospectively analyzed the data of 100 patients with meniscus injuries treated with knee arthroscopy from December 2022 to December 2023 and divided them into a control group and a modified group according to the application of "arthroscopic access modification technology". We compared the operation time, postoperative hospitalization time, VAS score, Lysholm knee function score, postoperative complications, and postoperative images of the patients in these two groups.

View Article and Find Full Text PDF

Background: The evidence indicates that functional training is beneficial for athletes' physical and technical performance. However, a systematic review of the effects of functional training on athletes' physical and technical performance is lacking. Therefore, this study uses a literature synthesis approach to evaluate the impact of functional training on the physical and technical performance of the athletic population and to extend and deepen the existing body of knowledge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!